Ethics. Research. Community.

Alzheimer’s Treatment Failed Trial, Maker Says

New York Times. 
[Record Source: New York Times]
Baxter International said that the immunoglobulin therapy did not significantly arrest the decline in either cognition or daily functioning when compared with a placebo.     
Access the full text from your libraries at your institution.  You will be navigating away from EthicShare.

Database Keywords

Detailed Record Information

Record TypeNews/Magazine Article
LicenseNone (All rights reserved) ©